New York Inventor Develops Cancer Invasion and Angiogenesis Inhibition Composition
Copyright © Targeted News Service 2007
2007-08-03
ALEXANDRIA, Va., Aug. 3 -- Wen-Tien Chen of Stony Brook, N.Y., has developed methods for inhibition of cancer invasion.
According to the U.S. Patent & Trademark Office: "The invention provides antibodies that specifically bind a membrane protease complex, the complex consisting of two homodimers of seprase and dipeptidyl peptidase IV (DPPIV), obtained from mammalian, preferably human cell membranes. The antibodies specifically bind the DPPIV protease of the seprase-DPPIV complex. . . .
According to the U.S. Patent & Trademark Office: "The invention provides antibodies that specifically bind a membrane protease complex, the complex consisting of two homodimers of seprase and dipeptidyl peptidase IV (DPPIV), obtained from mammalian, preferably human cell membranes. The antibodies specifically bind the DPPIV protease of the seprase-DPPIV complex. . . .